The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced new steps to reinforce its collaboration with the US Food and Drug Administration (FDA).
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced new steps to reinforce its collaboration with the US Food and Drug Administration (FDA).
From 16 June 2025, the Medical Devices Post-market Surveillance (PMS) Regulations apply to medical devices and IVDs placed on the market in Great Britain. Published in 2024, the new UK PMS Regulations amends the UK Medical Devices Regulations (MDR) 2002.
Discover key insights for placing medical devices on the UK market post-Brexit. Learn about UKCA and CE marking options, appointing a UK Responsible Person, MHRA registration, and regulatory compliance to access the Great Britain market.